Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy
Open Access
- 12 December 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13321
Abstract
CRISPR–Cas technology has transformed the field of gene editing, opening new possibilities for treatment of various genetic disorders. Recent years have seen a surge in clinical trials using CRISPR–Cas-based therapies. This review examines the current landscape of CRISPR–Cas implementation in clinical trials, with data from key registries, including the Australian New Zealand Clinical Trials Registry, the Chinese Clinical Trial Register, and ClinicalTrials.gov. Emphasis is placed on the mechanism of action of tested therapies, the delivery method, and the most recent findings of each clinical trial.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (075-15-2021-1085)
This publication has 139 references indexed in Scilit:
- Unintended CRISPR-Cas9 editing outcomes: a review of the detection and prevalence of structural variants generated by gene-editing in human cellsHuman Genetics, 2023
- Xenotransplantation becoming realityTransgenic Research, 2022
- A Brief History of XenotransplantationThe Annals of Thoracic Surgery, 2022
- CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cellsInternational Journal of Cancer, 2021
- CRISPR-based strategies in infectious disease diagnosis and therapyInfection, 2021
- CRISPR-Cas12a: Functional overview and applicationsBiomedical Journal, 2020
- Molecular basis of β thalassemia and potential therapeutic targetsBlood Cells, Molecules, and Diseases, 2018
- The CRISPR-Cas immune system: Biology, mechanisms and applicationsBiochimie, 2015
- Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic ElementsJournal of Molecular Evolution, 2005
- Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug usersHuman Genetics, 1998